Concepedia

Author

Denis Roy

Clinical Research InstituteORCID

Also Known As

D. K. Roy, D. Roy, Denis Roy, F. Gonzalvez

12

Publications

723

Citations

10

H-Index

25

Concepts

All Affiliations

Clinical Research InstituteBristol-Myers Squibb (United States)Duke Medical Center
DR

About

Denis Roy is an author at Clinical Research Institute specializing in medicine, pharmacology, and cardiovascular pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

440

2

Diabetes

2

2

128

3

Endocrinology

2

2

128

4

Health Sciences

1

1

91

5

Public Health

1

1

296

Denis Roy

×

8

Publications

538

Citations

8

H-Index

YearCitations

Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study

Jonathan P. Piccini, Valeria Caso, Stuart J. Connolly,

The Lancet

2022

296

Exenatide does not evoke pancreatitis and attenuates chemically induced pancreatitis in normal and diabetic rodents

Krystyna Tatarkiewicz, Pam Smith, Emmanuel J. Sablan,

American Journal of Physiology-Endocrinology and Metabolism

2010

91

No evidence of drug‐induced pancreatitis in rats treated with exenatide for 13 weeks

Krystyna Tatarkiewicz, P M Bélanger, Gyo‐Jeong Gu,

Diabetes Obesity and Metabolism

2012

56

Occurrence of Spontaneous Pancreatic Lesions in Normal and Diabetic Rats: A Potential Confounding Factor in the Nonclinical Assessment of GLP-1–Based Therapies

Kristina D. Chadwick, Anthony M. Fletcher, M. Cecilia M. Parrula,

Diabetes

2013

37

Nonclinical safety and pharmacokinetics of Miglyol 812: A medium chain triglyceride in exenatide once weekly suspension

Nicholas Buss, Patricia C. Ryan, Todd M. Baughman,

Journal of Applied Toxicology

2018

18

Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter

Joseph L. Blackshear, Bruce S. Stambler, William Strauss,

The American Journal of Cardiology

1996

16

The glucagon‐like peptide‐1‐based therapeutics exenatide and saxagliptin did not cause detrimental effects on the pancreas in mice, rats, dogs and monkeys

Denis Roy, Kristina D. Chadwick, Krystyna Tatarkiewicz,

Diabetes Obesity and Metabolism

2014

13

Multicenter, Phase 2, Randomized Controlled Study of the Efficacy and Safety of Etripamil Nasal Spray for the Acute Reduction of Rapid Ventricular Rate in Patients With Symptomatic Atrial Fibrillation (ReVeRA-201)

A. John Camm, Jonathan P. Piccini, Marco Alings,

Circulation Arrhythmia and Electrophysiology

2023

11

Page 1